Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Sell
605
-25
-4% -$10K 0.19% 87
2026
Q2
$228K Hold
630
– – 0.18% 92
2026
Q1
$222K Hold
630
– – 0.19% 89
2025
Q4
$206K Buy
+630
New +$200K 0.18% 94

Other funds holding AMGN

Bayban's AMGN Position: Q3 2026 in Review

Bayban reduced its Amgen (AMGN) stake by 4% in Q3 2026, selling an estimated $10K and leaving 605 shares worth $255K. The position accounts for 0.19% of the portfolio, ranked #87.

Bayban first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Bayban held 605 shares of Amgen worth $255K as of Q3 2026.
  • Bayban sold 25 Amgen shares in Q3 2026, an estimated $10K.
  • Amgen made up 0.19% of Bayban's portfolio in Q3 2026, its #87 holding.
  • Bayban first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.